Hereditary breast and ovarian cancer : molecular mechanism and clinical practice /

Saved in:
Bibliographic Details
Imprint:Singapore : Springer, 2021.
Description:1 online resource
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/12665585
Hidden Bibliographic Details
Other authors / contributors:Nakamura, Seigo, editor.
Aoki, Daisuke, editor.
Miki, Yoshio, editor.
ISBN:9789811645211
9811645213
9811645205
9789811645204
Notes:Online resource; title from PDF title page (SpringerLink, viewed November 4, 2021).
Summary:This highly informative and clearly written book presents the basic science and the latest data on hereditary breast and ovarian cancer (HBOC) to provide an up-to-date and holistic overview of the disease. It starts off by presenting the molecular mechanisms, genetic testing and counseling, and variants of unknown significance (VUS) to help readers understand the contemporary interpretation of the disease. Further chapters focus on the surveillance, diagnosis and treatment, including chemoprevention, risk reduction and drug development based on molecular mechanisms. It also includes a chapter on the latest findings from the HBOC database, ethical issues and the parp inhibitors, and discusses innovative thinking to manage and understand the disease. Hereditary Breast and Ovarian Cancer - Molecular Mechanism and Clinical Practice offers breast surgeons, medical oncologists, gynecological oncologists and genetic counselors a comprehensive overview of the disease. Providing insights into recent scientific findings and further avenues for investigation, it is also a thought-provoking and informative read for researchers and scholars.
Other form:Original 9811645205 9789811645204
Standard no.:10.1007/978-981-16-4521-1

MARC

LEADER 00000cam a2200000Ia 4500
001 12665585
006 m o d
007 cr |n|||||||||
008 211024s2021 si o 000 0 eng d
005 20240715195039.3
019 |a 1280197195  |a 1281967000  |a 1281980631  |a 1282200471  |a 1282202391 
020 |a 9789811645211  |q (electronic bk.) 
020 |a 9811645213  |q (electronic bk.) 
020 |z 9811645205 
020 |z 9789811645204 
024 7 |a 10.1007/978-981-16-4521-1  |2 doi 
035 |a (OCoLC)1280276097  |z (OCoLC)1280197195  |z (OCoLC)1281967000  |z (OCoLC)1281980631  |z (OCoLC)1282200471  |z (OCoLC)1282202391 
035 9 |a (OCLCCM-CC)1280276097 
040 |a YDX  |b eng  |c YDX  |d GW5XE  |d EQF  |d EBLCP 
049 |a MAIN 
050 4 |a RC280.B8 
072 7 |a MED062000  |2 bisacsh 
245 0 0 |a Hereditary breast and ovarian cancer :  |b molecular mechanism and clinical practice /  |c Seigo Nakamura, Daisuke Aoki, Yoshio Miki, editors. 
260 |a Singapore :  |b Springer,  |c 2021. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
505 0 |a 1 History, Advancements, and Future Strategies -- 2 Molecular basis of BRCA1 and BRCA2 - Homologous recombination deficiency and tissue-specific carcinogenesis -- 3 Genetic Testing -- 4 Variants of uncertain significances in hereditary breast and ovarian cancer -- 5 Genetic counseling in Hereditary Breast and Ovarian Cancer -- 6 Hereditary Breast Cancer -- 7 Hereditary Ovarian Cancer -- 8 Risk-Based Breast Cancer Screening -- 9 Chemoprevention for Breast Cancer -- 10 Chemoprevention for Ovarian Cancer -- 11 Risk-Reducing Mastectomy (RRM) -- 12 Risk-reducing salpingo-oophorectomy (RRSO) -- 13 Panel Testing -- 14 Germline Findings through Precision Oncology for Ovarian Cancer -- 15 Germline Findings from Genetic Testing for Breast Cancer -- 16 Hereditary Breast and Ovarian Cancer (HBOC) Database -- 17 Ethical Issues: Overview in Genomic analysis and Clinical Context -- 18 PARP Inhibitors-Mechanism of action -- 19 PARPi - Efficacy in Hereditary Breast Cancer -- 20 Efficacy of Poly ADP-Ribose Polymerase Inhibitors for Hereditary Ovarian Cancer. 
520 |a This highly informative and clearly written book presents the basic science and the latest data on hereditary breast and ovarian cancer (HBOC) to provide an up-to-date and holistic overview of the disease. It starts off by presenting the molecular mechanisms, genetic testing and counseling, and variants of unknown significance (VUS) to help readers understand the contemporary interpretation of the disease. Further chapters focus on the surveillance, diagnosis and treatment, including chemoprevention, risk reduction and drug development based on molecular mechanisms. It also includes a chapter on the latest findings from the HBOC database, ethical issues and the parp inhibitors, and discusses innovative thinking to manage and understand the disease. Hereditary Breast and Ovarian Cancer - Molecular Mechanism and Clinical Practice offers breast surgeons, medical oncologists, gynecological oncologists and genetic counselors a comprehensive overview of the disease. Providing insights into recent scientific findings and further avenues for investigation, it is also a thought-provoking and informative read for researchers and scholars. 
588 0 |a Online resource; title from PDF title page (SpringerLink, viewed November 4, 2021). 
650 0 |a Breast  |x Cancer  |x Genetic aspects. 
650 0 |a Breast  |x Cancer  |x Molecular aspects. 
650 0 |a Ovaries  |x Cancer  |x Genetic aspects. 
650 0 |a Ovaries  |x Cancer  |x Molecular aspects. 
655 4 |a Electronic books. 
655 0 |a Electronic books. 
700 1 |a Nakamura, Seigo,  |e editor. 
700 1 |a Aoki, Daisuke,  |e editor. 
700 1 |a Miki, Yoshio,  |e editor. 
776 0 8 |c Original  |z 9811645205  |z 9789811645204  |w (OCoLC)1257889835 
903 |a HeVa 
929 |a oclccm 
999 f f |i c1d33cff-6221-5772-bd8c-1f6039d6bff9  |s 2455a487-567a-5615-aae5-6da654ff3c66 
928 |t Library of Congress classification  |a RC280.B8  |l Online  |c UC-FullText  |u https://link.springer.com/10.1007/978-981-16-4521-1  |z Springer Nature  |g ebooks  |i 12721029